Albion Financial Group’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.11K | Buy |
+23
| New | +$1.07K | ﹤0.01% | 631 |
|
|
2025
Q1 | – | Sell |
-47
| Closed | -$2.27K | – | 679 |
|
|
2024
Q4 | $2.27K | Buy |
+47
| New | +$2.39K | ﹤0.01% | 549 |
|
|
2023
Q3 | – | Sell |
-25
| Closed | -$1.35K | – | 500 |
|
|
2023
Q2 | $1.35K | Buy |
+25
| New | +$1.34K | ﹤0.01% | 404 |
|
|
2022
Q3 | – | Sell |
-34
| Closed | -$2K | – | 555 |
|
|
2022
Q2 | $2K | Hold |
34
| – | – | ﹤0.01% | 429 |
|
|
2022
Q1 | $2K | Sell |
34
-34
| -50% | -$1.76K | ﹤0.01% | 488 |
|
|
2021
Q4 | $3K | Buy |
68
+1
| +1% | +$49 | ﹤0.01% | 495 |
|
|
2021
Q3 | $3K | Hold |
67
| – | – | ﹤0.01% | 444 |
|
|
2021
Q2 | $4K | Buy |
+67
| New | +$3.5K | ﹤0.01% | 427 |
|
|
2020
Q4 | $3K | Buy |
+67
| New | +$3.3K | ﹤0.01% | 412 |
|
|
2018
Q1 | – | Sell |
-10,088
| Closed | -$434K | – | 197 |
|
|
2017
Q4 | $434K | Hold |
10,088
| – | – | 0.07% | 136 |
|
|
2017
Q3 | $502K | Sell |
10,088
-40
| -0.4% | -$1.94K | 0.08% | 127 |
|
|
2017
Q2 | $485K | Hold |
10,128
| – | – | 0.08% | 127 |
|
|
2017
Q1 | $458K | Sell |
10,128
-188
| -2% | -$7.97K | 0.07% | 133 |
|
|
2016
Q4 | $417K | Sell |
10,316
-6,594
| -39% | -$260K | 0.07% | 128 |
|
|
2016
Q3 | $646K | Sell |
16,910
-10,269
| -38% | -$412K | 0.11% | 108 |
|
|
2016
Q2 | $1.14M | Buy |
27,179
+3,750
| +16% | +$154K | 0.2% | 65 |
|
|
2016
Q1 | $941K | Buy |
23,429
+6,265
| +37% | +$252K | 0.16% | 79 |
|
|
2015
Q4 | $732K | Sell |
17,164
-11,314
| -40% | -$521K | 0.13% | 95 |
|
|
2015
Q3 | $1.35M | Buy |
28,478
+545
| +2% | +$27.8K | 0.24% | 56 |
|
|
2015
Q2 | $1.38M | Buy |
27,933
+3,340
| +14% | +$169K | 0.23% | 58 |
|
|
2015
Q1 | $1.22M | Buy |
24,593
+1,920
| +8% | +$91.8K | 0.21% | 61 |
|
|
2014
Q4 | $1.03M | Sell |
22,673
-4,570
| -17% | -$222K | 0.18% | 70 |
|
|
2014
Q3 | $1.54M | Buy |
27,243
+225
| +0.8% | +$12.1K | 0.27% | 53 |
|
|
2014
Q2 | $1.44M | Buy |
27,018
+2,140
| +9% | +$114K | 0.25% | 58 |
|
|
2014
Q1 | $1.3M | Buy |
24,878
+2,652
| +12% | +$134K | 0.24% | 63 |
|
|
2013
Q4 | $1.19M | Buy |
22,226
+9,395
| +73% | +$485K | 0.22% | 65 |
|
|
2013
Q3 | $650K | Buy |
12,831
+7,385
| +136% | +$376K | 0.14% | 85 |
|
|
2013
Q2 | $281K | Buy |
+5,446
| New | +$290K | 0.06% | 122 |
|
Other funds holding SNY
MIP
Albion Financial Group's SNY Position: Q1 2026 in Review
Albion Financial Group opened a new position in Sanofi (SNY) in Q1 2026: 23 shares worth $1.11K. The stake represents ﹤0.01% of the portfolio and ranks #631 among its holdings. This is a return to the name: Albion Financial Group previously reported a position in SNY as recently as Q4 2024.
Albion Financial Group first reported a position in SNY in Q2 2013 and has held it in 28 quarters since. The position peaked at $1.54M in Q3 2014. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- Albion Financial Group held 23 shares of Sanofi worth $1.11K as of Q1 2026.
- Sanofi was a new Albion Financial Group position in Q1 2026.
- Sanofi made up ﹤0.01% of Albion Financial Group's portfolio in Q1 2026, its #631 holding.
- Albion Financial Group first reported a position in Sanofi in Q2 2013 and has held it in 28 quarters since.
- Albion Financial Group's Sanofi position peaked at $1.54M in Q3 2014.
- 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on Albion Financial Group's 13F filing for Q1 2026, filed 27 Apr 2026.